TN2009000529A1 - Methods and compositions for treating allergic diseases - Google Patents
Methods and compositions for treating allergic diseasesInfo
- Publication number
- TN2009000529A1 TN2009000529A1 TNP2009000529A TN2009000529A TN2009000529A1 TN 2009000529 A1 TN2009000529 A1 TN 2009000529A1 TN P2009000529 A TNP2009000529 A TN P2009000529A TN 2009000529 A TN2009000529 A TN 2009000529A TN 2009000529 A1 TN2009000529 A1 TN 2009000529A1
- Authority
- TN
- Tunisia
- Prior art keywords
- methods
- compositions
- allergic diseases
- treating allergic
- antibodies
- Prior art date
Links
- 208000026935 allergic disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 101000956427 Homo sapiens Cytokine receptor-like factor 2 Proteins 0.000 abstract 1
- 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 abstract 1
- 102100031294 Thymic stromal lymphopoietin Human genes 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000011664 signaling Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94520507P | 2007-06-20 | 2007-06-20 | |
| PCT/EP2008/057731 WO2008155365A1 (fr) | 2007-06-20 | 2008-06-18 | Procédés et compositions pour traiter des maladies allergiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2009000529A1 true TN2009000529A1 (en) | 2011-03-31 |
Family
ID=39846944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2009000529A TN2009000529A1 (en) | 2007-06-20 | 2009-12-17 | Methods and compositions for treating allergic diseases |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8101182B2 (fr) |
| EP (1) | EP2170957A1 (fr) |
| JP (1) | JP2010530233A (fr) |
| KR (1) | KR20100034015A (fr) |
| CN (1) | CN102027012A (fr) |
| AR (1) | AR067045A1 (fr) |
| AU (1) | AU2008265128A1 (fr) |
| BR (1) | BRPI0813725A2 (fr) |
| CA (1) | CA2691157A1 (fr) |
| CL (1) | CL2008001826A1 (fr) |
| CO (1) | CO6251325A2 (fr) |
| CR (1) | CR11152A (fr) |
| EA (1) | EA201000006A1 (fr) |
| EC (1) | ECSP099812A (fr) |
| IL (1) | IL202573A0 (fr) |
| PE (1) | PE20090768A1 (fr) |
| TN (1) | TN2009000529A1 (fr) |
| TW (1) | TW200918557A (fr) |
| WO (1) | WO2008155365A1 (fr) |
| ZA (1) | ZA200908711B (fr) |
Families Citing this family (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2288036T5 (es) | 1998-11-13 | 2017-07-06 | Immunex Corporation | ADN de TSLP humano y polipéptidos |
| DK1417231T3 (da) | 2001-07-23 | 2013-07-22 | Immunex Corp | Modificeret human thymisk stromal lymphopoietin |
| JP5781762B2 (ja) * | 2007-08-10 | 2015-09-24 | プロテリックス、インク | ユニバーサルｉｉｉ型フィブロネクチン結合ドメインのライブラリ |
| US8470966B2 (en) | 2007-08-10 | 2013-06-25 | Protelica, Inc. | Universal fibronectin type III binding-domain libraries |
| US8680019B2 (en) * | 2007-08-10 | 2014-03-25 | Protelica, Inc. | Universal fibronectin Type III binding-domain libraries |
| US7982016B2 (en) | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| CA2713935C (fr) * | 2008-02-07 | 2016-11-01 | Schering Corporation | Anticorps anti-tslpr mis au point |
| WO2012007495A1 (fr) * | 2010-07-15 | 2012-01-19 | F. Hoffmann-La Roche Ag | Anticorps se liant spécifiquement aux tslpr humains et procédés d'utilisation |
| KR101221649B1 (ko) * | 2010-11-01 | 2013-01-14 | 광주과학기술원 | 알러지 질환의 예방 또는 치료용 약제학적 조성물, 그의 스크리닝 방법 |
| PT3031913T (pt) | 2013-08-09 | 2019-05-31 | Astellas Pharma Inc | Novo anticorpo anti-receptor de tslp humana |
| CA2945026C (fr) | 2014-05-07 | 2023-10-10 | Amgen Inc. | Auto-injecteur comprenant des elements de reduction de choc |
| EP3467501B1 (fr) | 2014-05-16 | 2020-11-04 | Amgen Inc. | Dosage pour la détection de populations de cellules th1 et th2 |
| CA2948525A1 (fr) | 2014-06-03 | 2015-12-10 | Amgen Inc. | Systeme d'administration de medicament pouvant etre commande et son procede d'utilisation |
| US10695506B2 (en) | 2014-10-14 | 2020-06-30 | Amgen Inc. | Drug injection device with visual and audio indicators |
| KR102534017B1 (ko) | 2014-10-23 | 2023-05-19 | 암젠 인크 | 약제학적 제형의 점도 감소 |
| EP3233159B1 (fr) | 2014-12-19 | 2020-03-04 | Amgen Inc. | Dispositif d'administration de medicaments avec bouton bouge ou panneau d'interface utilisateur |
| CA2976935C (fr) | 2015-02-17 | 2020-03-10 | Amgen Inc. | Dispositif d'administration de medicament a securisation assistee par depression et/ou retour d'informations |
| US11806509B2 (en) | 2015-02-27 | 2023-11-07 | Amgen Inc. | Drug delivery device having a needle guard mechanism with a turnable threshold of resistance to needle guard movement |
| WO2017039786A1 (fr) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Adaptateur d'ensemble de seringue pour une seringue |
| AU2016320748B2 (en) | 2015-09-09 | 2019-05-02 | Novartis Ag | Thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of using the antibodies |
| MA55472A (fr) | 2015-09-09 | 2022-02-09 | Novartis Ag | Molécules de liaison de lymphopoïétine stromale thymique (tslp) et procédés d'utilisation des molécules |
| JP7082568B2 (ja) | 2015-12-09 | 2022-06-08 | アムジエン・インコーポレーテツド | 信号伝達キャップ付き自動注射器 |
| PH12018501243B1 (en) | 2015-12-18 | 2022-11-04 | Upstream Bio Inc | Pharmaceutical composition comprising anti-human tslp receptor antibody |
| WO2017120178A1 (fr) | 2016-01-06 | 2017-07-13 | Amgen Inc. | Auto-injecteur pourvu d'une électronique de signalisation |
| EP3429663B1 (fr) | 2016-03-15 | 2020-07-15 | Amgen Inc. | Réduction de la probabilité de casse du verre dans des dispositifs d'administration de médicament |
| US11541168B2 (en) | 2016-04-29 | 2023-01-03 | Amgen Inc. | Drug delivery device with messaging label |
| WO2017192287A1 (fr) | 2016-05-02 | 2017-11-09 | Amgen Inc. | Adaptateur de seringue et guide pour remplir un injecteur sur le corps |
| EP3455142B1 (fr) | 2016-05-13 | 2023-08-09 | Amgen Inc. | Ensemble manchon de flacon |
| WO2017200989A1 (fr) | 2016-05-16 | 2017-11-23 | Amgen Inc. | Chiffrement de données dans des dispositifs médicaux à capacité de calcul limitée |
| WO2017209899A1 (fr) | 2016-06-03 | 2017-12-07 | Amgen Inc. | Appareils et procédés d'essai au choc destinés aux dispositifs d'administration de médicaments |
| EP3478342B1 (fr) | 2016-07-01 | 2025-03-12 | Amgen Inc. | Dispositif d'administration de médicament présentant un risque réduit au minimum de fracture de composant lors d'événements d'impact |
| US20190328965A1 (en) | 2016-08-17 | 2019-10-31 | Amgen Inc. | Drug delivery device with placement detection |
| US20200261643A1 (en) | 2016-10-25 | 2020-08-20 | Amgen Inc. | On-body injector |
| US20190358411A1 (en) | 2017-01-17 | 2019-11-28 | Amgen Inc. | Injection devices and related methods of use and assembly |
| AU2018220538B2 (en) | 2017-02-17 | 2023-12-14 | Amgen Inc. | Drug delivery device with sterile fluid flowpath and related method of assembly |
| JP7280189B2 (ja) | 2017-02-17 | 2023-05-23 | アムジエン・インコーポレーテツド | 薬物送達装置用の挿入機構 |
| JP7377596B2 (ja) | 2017-02-22 | 2023-11-10 | アムジエン・インコーポレーテツド | 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法 |
| CA3050927A1 (fr) | 2017-03-06 | 2018-09-13 | Brian Stonecipher | Dispositif d'administration de medicaments dote d'une fonction de prevention d'activation |
| CA3052482A1 (fr) | 2017-03-07 | 2018-09-13 | Amgen Inc. | Insertion d'aiguille par surpression |
| EP3592404A1 (fr) | 2017-03-09 | 2020-01-15 | Amgen Inc. | Mécanisme d'insertion pour dispositif d'administration de médicament |
| KR102517342B1 (ko) | 2017-03-28 | 2023-03-31 | 암겐 인코포레이티드 | 플런저 로드 및 주사기 조립 시스템 및 방법 |
| CA3059369A1 (fr) | 2017-04-28 | 2018-11-01 | Amgen Inc. | Dipeptides n-acetyles et non acetyles contenant de l'arginine destines a reduire la viscosite de compositions visqueuses de polypeptides therapeutiques |
| CN110709121B (zh) | 2017-06-08 | 2022-06-24 | 安进公司 | 扭矩驱动式药物递送装置 |
| AU2018280054B2 (en) | 2017-06-08 | 2023-07-13 | Amgen Inc. | Syringe assembly for a drug delivery device and method of assembly |
| US11541183B2 (en) | 2017-06-22 | 2023-01-03 | Amgen Inc. | Device activation impact/shock reduction |
| WO2018237225A1 (fr) | 2017-06-23 | 2018-12-27 | Amgen Inc. | Dispositif électronique d'administration de médicament comprenant un bouchon activé par un ensemble commutateur |
| EP3651832B1 (fr) | 2017-07-14 | 2023-12-13 | Amgen Inc. | Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion |
| WO2019018169A1 (fr) | 2017-07-21 | 2019-01-24 | Amgen Inc. | Élément d'étanchéité perméable aux gaz pour récipient à médicament et procédés d'assemblage |
| JP7242562B2 (ja) | 2017-07-25 | 2023-03-20 | アムジエン・インコーポレーテツド | 容器アクセスシステムを有する薬物送達デバイス及び関連する組立方法 |
| EP4085942A1 (fr) | 2017-07-25 | 2022-11-09 | Amgen Inc. | Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé |
| EP3662288B1 (fr) | 2017-08-01 | 2024-02-28 | Amgen Inc. | Systèmes et procédés d'analyse en temps réel du glycan contenu d'un echantilion |
| ES2978396T3 (es) | 2017-08-01 | 2024-09-11 | Amgen Inc | Sistemas y métodos para la preparación en tiempo real de una muestra de polipéptidos para el análisis por espectrometría de masas |
| MA49838A (fr) | 2017-08-09 | 2020-06-17 | Amgen Inc | Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre |
| EP3668567A1 (fr) | 2017-08-18 | 2020-06-24 | Amgen Inc. | Injecteur sur-corps avec patch adhésif stérile |
| US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
| US11759565B2 (en) | 2017-10-04 | 2023-09-19 | Amgen Inc. | Flow adapter for drug delivery device |
| MA50614A (fr) | 2017-10-06 | 2020-08-12 | Amgen Inc | Dispositif d'administration de médicament comprenant un ensemble de verrouillage et procédé d'assemblage associé |
| MA50348A (fr) | 2017-10-09 | 2020-08-19 | Amgen Inc | Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé |
| WO2019090086A1 (fr) | 2017-11-03 | 2019-05-09 | Amgen Inc. | Systèmes et approches pour stériliser un dispositif d'administration de médicament |
| MA50553A (fr) | 2017-11-06 | 2020-09-16 | Amgen Inc | Dispositif d'administration de médicament avec détection de positionnement et de débit |
| EP3707075A1 (fr) | 2017-11-06 | 2020-09-16 | Amgen Inc. | Ensembles de remplissage-finition et procédés associés |
| US11191904B2 (en) | 2017-11-10 | 2021-12-07 | Amgen Inc. | Plungers for drug delivery devices |
| CN111278487B (zh) | 2017-11-16 | 2022-06-24 | 安进公司 | 用于药物递送装置的门闩锁机构 |
| ES2965064T3 (es) | 2018-03-13 | 2024-04-10 | Amgen Inc | Métodos para la preparación de polipéptidos resistentes a tripsina para análisis espectrométrico de masas |
| JP7411560B2 (ja) | 2018-03-13 | 2024-01-11 | アムジエン・インコーポレーテツド | 質量分光測定法による分析のためのポリペプチドの連続消化 |
| US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
| US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
| KR102682705B1 (ko) * | 2018-07-04 | 2024-07-05 | 고려대학교 세종산학협력단 | 옥사졸로퀴놀리논 유도체를 유효성분으로 포함하는 우울증 및 스트레스 관련 질환의 예방 또는 치료용 약학 조성물 |
| WO2020023336A1 (fr) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Dispositifs hybrides d'administration de médicament dotés d'une partie de préhension |
| WO2020023451A1 (fr) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Dispositifs d'administration pour l'administration de médicaments |
| MX2021000748A (es) | 2018-07-24 | 2021-03-26 | Amgen Inc | Dispositivos de suministro para administrar farmacos. |
| WO2020023220A1 (fr) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Dispositifs d'administration de médicament hybrides dotés d'une partie de fixation collante à placer sur la peau et procédé de préparation associé |
| CA3103105A1 (fr) | 2018-07-31 | 2020-02-06 | Amgen Inc. | Ensemble de trajet de fluide pour dispositif d'administration de medicament |
| EP3856284A1 (fr) | 2018-09-24 | 2021-08-04 | Amgen Inc. | Systèmes et procédés de dosage interventionnel |
| EP3856283A1 (fr) | 2018-09-28 | 2021-08-04 | Amgen Inc. | Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament |
| MA53815A (fr) | 2018-10-02 | 2022-01-05 | Amgen Inc | Systèmes d'injection pour administration de médicament avec transmission de force interne |
| US12151089B2 (en) | 2018-10-05 | 2024-11-26 | Amgen Inc. | Drug delivery device having dose indicator |
| US12053617B2 (en) | 2018-10-15 | 2024-08-06 | Amgen Inc. | Drug delivery device having damping mechanism |
| US20210346596A1 (en) | 2018-10-15 | 2021-11-11 | Amgen Inc. | Platform assembly process for drug delivery device |
| IL281908B2 (en) | 2018-11-01 | 2025-06-01 | Amgen Inc | Drug delivery devices with partial drug delivery member retraction |
| WO2020091956A1 (fr) | 2018-11-01 | 2020-05-07 | Amgen Inc. | Dispositifs d'administration de médicament avec rétraction partielle de l'organe d'administration de médicament |
| TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
| CA3126018A1 (fr) | 2018-12-14 | 2020-06-18 | Amgen Inc. | Procede d'adequation de systeme destine a etre utilise avec une determination de concentration de proteine par pente |
| JP7483731B2 (ja) | 2019-02-14 | 2024-05-15 | アムジエン・インコーポレーテツド | 試料の調製及びその試料のリアルタイムアッセイの実施のためのシステム及び方法 |
| JP7530376B2 (ja) | 2019-02-20 | 2024-08-07 | アムジエン・インコーポレーテツド | タンパク質の安定性を決定する方法 |
| JP7570341B2 (ja) | 2019-03-04 | 2024-10-21 | アムジエン・インコーポレーテツド | 高分子量種のインビボでの可逆性 |
| EP3948242A1 (fr) | 2019-03-27 | 2022-02-09 | Amgen Inc. | Méthodes de cartographie de protéines thérapeutiques par l'intermédiaire d'une technique de résonance magnétique nucléaire bidimensionnelle (2d) à une abondance naturelle pour produits biopharmaceutiques formulés |
| CA3137360A1 (fr) | 2019-04-24 | 2020-10-29 | Amgen Inc. | Ensembles et procedes de verification de sterilisation de seringue |
| KR20220016897A (ko) | 2019-06-04 | 2022-02-10 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 흉선 기질 림포포이에틴에 결합할 수 있는 항체 및 이의 용도 |
| ES2997211T3 (en) | 2019-06-05 | 2025-02-14 | Amgen Inc | Methods of identifying attributes of therapeutic proteins |
| CA3148261A1 (fr) | 2019-08-23 | 2021-03-04 | Amgen Inc. | Dispositif d'administration de medicament dote de composants configurables de mise en prise de protection d'aiguille et methodes associees |
| RS66646B1 (sr) | 2019-10-28 | 2025-04-30 | Medimmune Ltd | Formulacije suvog praška vezujućih antitela za timusni stromalni limfopoetin (tslp) i postupci njihove upotrebe |
| CN111171150B (zh) * | 2020-02-05 | 2020-12-08 | 北京智仁美博生物科技有限公司 | 抗人tslp抗体及其用途 |
| AU2021343495A1 (en) | 2020-09-18 | 2023-04-27 | Amgen Inc. | Methods of processing a sample for peptide mapping analysis |
| AU2021376246A1 (en) | 2020-11-05 | 2023-06-08 | Amgen Inc. | Materials and methods for protein processing |
| BR112023024278A2 (pt) | 2021-05-21 | 2024-01-30 | Amgen Inc | Método de otimizar uma receita de enchimento para um recipiente de fármacos |
| WO2023086793A1 (fr) | 2021-11-09 | 2023-05-19 | Amgen Inc. | Production de protéines thérapeutiques |
| US12150991B2 (en) | 2022-11-07 | 2024-11-26 | Upstream Bio, Inc. | Pharmaceutical compositions comprising anti-human TSLP receptor antibodies and methods of using the same |
| WO2024259275A1 (fr) | 2023-06-14 | 2024-12-19 | Bristol-Myers Squibb Company | Quantification en temps quasi réel d'acide sialique de glycoprotéines |
| WO2025101602A1 (fr) | 2023-11-07 | 2025-05-15 | Amgen Inc. | Procédés d'analyse de la teneur en acides aminés d'une protéine thérapeutique |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE490980T1 (de) | 1998-03-19 | 2010-12-15 | Human Genome Sciences | Der gemeinsamen gamma-kette ähnlicher zytokinrezeptor |
| ES2391124T3 (es) | 2000-06-28 | 2012-11-21 | Amgen Inc. | Moléculas de receptor de linfopoyetina estromal tímica y usos de las mismas |
| WO2002000723A2 (fr) | 2000-06-28 | 2002-01-03 | Whitehead Institute For Biomedical Research | Molecules de recepteur de lymphopoietine de stroma thymique et utilisations de celles-ci |
| US6890734B2 (en) | 2000-11-10 | 2005-05-10 | Schering Corporation | Nucleic acids encoding a cytokine receptor complex |
| PT2311869E (pt) * | 2002-02-01 | 2013-03-04 | Merck Sharp & Dohme | Utilização de reagentes relacionados com citoquinas de mamíferos |
| ES2313076T3 (es) * | 2003-07-18 | 2009-03-01 | Schering Corporation | Tratamiento y diagnostico de neoplasias usando linfopoyetina estromal timica. |
| US20050249712A1 (en) * | 2004-03-23 | 2005-11-10 | The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services | Methods for use of TSLP and agonists and antagonists thereof |
| WO2006023791A2 (fr) * | 2004-08-20 | 2006-03-02 | Amgen Inc. | Procedes et compositions pour le traitement d'inflammation allergique |
| US20060171943A1 (en) | 2005-02-01 | 2006-08-03 | Amgen Inc. | Compositions and methods of treating fibrotic disorders |
| CA2635599C (fr) * | 2006-01-13 | 2014-06-17 | Irm Llc | Procedes et compositions permettant de traiter des maladies alleriques |
| CA2713935C (fr) | 2008-02-07 | 2016-11-01 | Schering Corporation | Anticorps anti-tslpr mis au point |
-
2008
- 2008-06-18 BR BRPI0813725-0A2A patent/BRPI0813725A2/pt not_active IP Right Cessation
- 2008-06-18 US US12/141,516 patent/US8101182B2/en not_active Expired - Fee Related
- 2008-06-18 WO PCT/EP2008/057731 patent/WO2008155365A1/fr not_active Ceased
- 2008-06-18 KR KR1020107001185A patent/KR20100034015A/ko not_active Ceased
- 2008-06-18 JP JP2010512681A patent/JP2010530233A/ja active Pending
- 2008-06-18 AU AU2008265128A patent/AU2008265128A1/en not_active Abandoned
- 2008-06-18 EA EA201000006A patent/EA201000006A1/ru unknown
- 2008-06-18 AR ARP080102594A patent/AR067045A1/es not_active Application Discontinuation
- 2008-06-18 CN CN2008801025460A patent/CN102027012A/zh active Pending
- 2008-06-18 CA CA2691157A patent/CA2691157A1/fr not_active Abandoned
- 2008-06-18 EP EP08761179A patent/EP2170957A1/fr not_active Withdrawn
- 2008-06-18 PE PE2008001045A patent/PE20090768A1/es not_active Application Discontinuation
- 2008-06-19 TW TW097122910A patent/TW200918557A/zh unknown
- 2008-06-19 CL CL2008001826A patent/CL2008001826A1/es unknown
-
2009
- 2009-12-07 IL IL202573A patent/IL202573A0/en unknown
- 2009-12-08 ZA ZA200908711A patent/ZA200908711B/xx unknown
- 2009-12-09 CR CR11152A patent/CR11152A/es not_active Application Discontinuation
- 2009-12-17 CO CO09144825A patent/CO6251325A2/es not_active Application Discontinuation
- 2009-12-17 TN TNP2009000529A patent/TN2009000529A1/fr unknown
- 2009-12-18 EC EC2009009812A patent/ECSP099812A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010530233A (ja) | 2010-09-09 |
| CL2008001826A1 (es) | 2009-02-20 |
| AU2008265128A1 (en) | 2008-12-24 |
| US20090074747A1 (en) | 2009-03-19 |
| ZA200908711B (en) | 2010-08-25 |
| US8101182B2 (en) | 2012-01-24 |
| BRPI0813725A2 (pt) | 2014-12-30 |
| CN102027012A (zh) | 2011-04-20 |
| ECSP099812A (es) | 2010-01-29 |
| KR20100034015A (ko) | 2010-03-31 |
| PE20090768A1 (es) | 2009-07-09 |
| CR11152A (es) | 2010-01-20 |
| EP2170957A1 (fr) | 2010-04-07 |
| AR067045A1 (es) | 2009-09-30 |
| WO2008155365A1 (fr) | 2008-12-24 |
| EA201000006A1 (ru) | 2010-10-29 |
| CA2691157A1 (fr) | 2008-12-24 |
| TW200918557A (en) | 2009-05-01 |
| CO6251325A2 (es) | 2011-02-21 |
| IL202573A0 (en) | 2011-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2009000529A1 (en) | Methods and compositions for treating allergic diseases | |
| TW200736275A (en) | Methods and compositions for treating allergic diseases | |
| MY165273A (en) | Anti-cd48 antibodies and uses thereof | |
| MY162511A (en) | Engineered anti-tslp antibody | |
| MX2010004327A (es) | Anticuerpos anti-vegf completamente humanos y metodos de uso. | |
| PH12015501806A1 (en) | Novel benzopyran kinase modulators | |
| PH12013500355A1 (en) | Engineered anti-tslp antibody | |
| UA108198C2 (uk) | Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування | |
| SG178602A1 (en) | Dual variable domain immunoglobulins and uses thereof | |
| PH12012500774A1 (en) | Dual variable domain immunoglobulins and uses thereof | |
| PH12012500815A1 (en) | Dual variable domain immunoglobulins and uses thereof | |
| MX2012004415A (es) | Inmunoglobulinas de dominio variable doble y usos de las mismas. | |
| MX2012001262A (es) | Inmunoglobulinas de dominio variable doble y usos de las misma. | |
| MX2011011669A (es) | Inmunoglobulinas de dominio variable dual y usos de las misma. | |
| MX2010008688A (es) | Anticuerpos anti-receptor de linfopoyetina estromal timica procesados por ingenieria. | |
| PH12017500864A1 (en) | Anti-notch1 antibodies | |
| MX338397B (es) | Anticuerpos anti - cxcr5 humanizados, derivados de los mismos y su uso. | |
| MX2012004078A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
| MX2013001267A (es) | ANTICUERPOS A IL-1ß E EIL-18 PARA TRATAMIENTO DE ENFERMEDAD. | |
| PH12015501360A1 (en) | Bmp-6 antibodies | |
| MX357166B (es) | Anticuerpos que se unen a notum pectinacetilesterasa. | |
| MX2010003373A (es) | Moduladores de receptores muscarinicos. | |
| AU2014256372B2 (en) | New compositions for treating CMT and related disorders | |
| TN2010000463A1 (en) | Compositions and methods for preparing and using same | |
| MX371027B (es) | Moduladores novedosos de benzopiran cinasa. |